Asia Pacific Biodefense Market is expected to reach US$ 723.70 Mn in 2027

Published Date: 29 Apr 2020

Report : Asia Pacific Biodefense Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Anthrax, Small pox, Botulism, Radiation/Nuclear, Others), and Geography

The Anthrax Segment by Product is expected to grow at A Fast Pace over the Forecast Period

 

According to The Insight Partners market research study of ‘Asia Pacific Biodefense Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Product’ The Asia Pacific Biodefense market is expected to reach US$ 1,520.67 Mn in 2027 from 723.70 Mn in 2019. The market is estimated to grow with a CAGR of 9.8% from 2020-2027. The report provides trends prevailing in the Asia Pacific Biodefense market and the factors driving market along with those that act as hindrances.

 

The Asia Pacific Biodefense market, based on the product, is segmented into Anthrax, Small pox, Botulism, and Radiation/Nuclear. The Anthrax segment held the largest share of the market in 2019 and also estimated to register the highest CAGR in the market during the forecast period owing to increasing funding by the governments of other countries to develop and stockpile adequate vaccines against anthrax mainly through a variety of initiatives in Asian countries, such as safe and security initiative , Special Measures Act for Pandemic preparedness, Civilian Protection Act and the Defense Research and Development Establishment (DRDE).

 

The Asia Pacific Biodefense market is expected to grow, owing to presence of favorable government initiatives increase in the number of naturally occurring outbreaks, increasing threat of biological weapons and nuclear armed ICBM. However, low R&D funding by government in developing and underdeveloped economies is expected to restraint the growth of the market during the forecast years.

 

Leading companies operating in the Asia Pacific Biodefense market are as Bavarian Nordic, Alnylam Pharmaceuticals, Inc., SIGA Technologies, Emergent BioSolutions Inc., and Cleveland Bio Labs among others.

 

Asia Pacific Biodefense Market, By Regions, 2019 (%)

Asia Pacific Biodefense Market, By Regions, 2019 (%)

The report segments Asia Pacific Biodefense market as follows:

 

Asia Pacific Biodefense Market – By Product

  • Anthrax
  • Small pox
  • Botulism
  • Radiation/Nuclear

 

Asia Pacific Biodefense Market– By Geography

  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia

 

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876

 

Download PDF Brochure